Doyle Anthony

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(2%)0%0%0%
Purchase Success Rate0 of 20 of 20 of 20 of 20 of 2
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Chief Financial Officer:

Holdings: 227.44K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--